Microbe-Induced inflammatory signals triggering acquired bone marrow failure syndromes

Frontiers in Immunology

Volumn 8, Issue FEB, 2017, Pages

  Espinoza, J Luis ^a   Kotecha, Ritesh ^b   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Aplastic anemia; Bone marrow failure syndromes; Microbe immunity; Microbioma; Virus induced anemia

Indexed keywords

CXCL3 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PATHOGEN ASSOCIATED MOLECULAR PATTERN; SHORT CHAIN FATTY ACID; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

BACTERIAL INFECTION; BONE MARROW APLASIA; BONE MARROW DEPRESSION; DENGUE VIRUS; EPSTEIN BARR VIRUS; GRANULOMATOUS INFLAMMATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEPATITIS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PARVOVIRUS B19; INFLAMMATION; NONHUMAN; PANCYTOPENIA; SHORT SURVEY;

EID: 85014413818     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00186     Document Type: Short Survey

References (98)

1. Nakao S. Guest editorial: advances in the management of acquired aplastic anemia. Int J Hematol (2013) 97:551-2. doi: 10.1007/s12185-013-1325-9
2. Dezern AE, Brodsky RA. Clinical management of aplastic anemia. Expert Rev Hematol (2011) 4:221-30. doi:10.1586/ehm.11.11
3. Hartung HD, Olson TS, Bessler M. Acquired aplastic anemia in children. Pediatr Clin North Am (2013) 60:1311-36. doi:10.1016/j.pcl.2013.08.011
4. Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program (2013) 2013:76-81. doi:10.1182/asheducation-2013.1.76
5. Zeng Y, Katsanis E. The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol (2015) 180:361-70. doi:10.1111/cei.12605
6. Espinoza J, Takamatsu H, Lu X, Qi Z, Nakao S. Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway. Int Immunol (2009) 21:913-23. doi:10.1093/intimm/dxp058
7. Takamatsu H, Espinoza J, Lu X, Qi Z, Okawa K, Nakao S. Anti-moesin antibodies in the serum of patients with aplastic anemia stimulate peripheral blood mononuclear cells to secrete TNF-alpha and IFN-gamma. J Immunol (2009) 182:703-10. doi:10.4049/jimmunol.182.1.703
8. Feng X, Chuhjo T, Sugimori C, Kotani T, Lu X, Takami A, et al. Diazepam-binding inhibitor-related protein 1: a candidate autoantigen in acquired aplastic anemia patients harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells. Blood (2004) 104:2425-31. doi:10.1182/blood-2004-05-1839
9. Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood (2016) 28(3):337-47. doi:10.1182/blood-2016-01-636381
10. Chalayer E, Ffrench M, Cathébras P. Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review. Rheumatol Int (2015) 35:1073-82. doi:10.1007/s00296-014-3162-4
11. Espinoza JL, Elbadry MI, Nakao S. An altered gut microbiota may trigger autoimmune-mediated acquired bone marrow failure syndromes. Clin Immunol (2016) 171:62-4. doi:10.1016/j.clim.2016.08.008
12. Ghavidel A. Ulcerative colitis associated with aplastic anemia; a case report. Middle East J Dig Dis (2013) 5:230-4.
13. de Oliveira LR, Ferreira TC, Neves FF, Meneses AC. Aplastic anemia associated to systemic lupus erythematosus in an AIDS patient: a case report. Rev Bras Hematol Hemoter (2013) 35:366-8. doi:10.5581/1516-8484.20130100
14. Morinet F, Leruez-Ville M, Pillet S, Fichelson S. Concise review: anemia caused by viruses. Stem Cells (2011) 29:1656-60. doi:10.1002/stem.725
15. Riether C, Schürch CM, Ochsenbein AF. Regulation of hematopoietic and leukemic stem cells by the immune system. Cell Death Differ (2015) 22:187-98. doi:10.1038/cdd.2014.89
16. Pietras EM, Warr MR, Passegué E. Cell cycle regulation in hematopoietic stem cells. J Cell Biol (2011) 195:709-20. doi:10.1083/jcb.201102131
17. Baldridge MT, King KY, Goodell MA. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol (2011) 32:57-65. doi:10.1016/j.it.2010.12.003
18. Scumpia PO, Kelly-Scumpia KM, Delano MJ, Weinstein JS, Cuenca AG, Al-Quran S, et al. Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol (2010) 184:2247-51. doi:10.4049/jimmunol.0903652
19. Pascutti MF, Erkelens MN, Nolte MA. Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on bone marrow output. Front Immunol (2016) 7:364. doi:10.3389/fimmu.2016.00364
20. Mirantes C, Passegué E, Pietras EM. Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. Exp Cell Res (2014) 329:248-54. doi:10.1016/j.yexcr.2014.08.017
21. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature (2009) 458:904-8. doi:10.1038/nature07815
22. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med (2009) 15:696-700. doi:10.1038/nm.1973
23. Rezzoug F, Huang Y, Tanner MK, Wysoczynski M, Schanie CL, Chilton PM, et al. TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol (2008) 180:49-57. doi:10.4049/jimmunol.180.1.49
24. Schürch CM, Riether C, Ochsenbein AF. Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell (2014) 14:460-72. doi:10.1016/j.stem.2014.01.002
25. Furusawa J, Mizoguchi I, Chiba Y, Hisada M, Kobayashi F, Yoshida H, et al. Promotion of expansion and differentiation of hematopoietic stem cells by interleukin-27 into myeloid progenitors to control infection in emergency myelopoiesis. PLoS Pathog (2016) 12:e1005507. doi:10.1371/journal.ppat.1005507
26. de Bruin AM, Demirel ö, Hooibrink B, Brandts CH, Nolte MA. Interferon-γ impairs proliferation of hematopoietic stem cells in mice. Blood (2013) 121:3578-85. doi:10.1182/blood-2012-05-432906
27. de Bruin AM, Voermans C, Nolte MA. Impact of interferon-γ on hematopoiesis. Blood (2014) 124:2479-86. doi:10.1182/blood-2014-04-568451
28. Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis (2015) 26:26050. doi:10.3402/mehd.v26.26050
29. Dollé L, Tran HQ, Etienne-Mesmin L, Chassaing B. Policing of gut microbiota by the adaptive immune system. BMC Med (2016) 14:27. doi:10.1186/s12916-016-0573-y
30. Bashan A, Gibson TE, Friedman J, Carey VJ, Weiss ST, Hohmann EL, et al. Universality of human microbial dynamics. Nature (2016) 534:259-62. doi:10.1038/nature18301
31. Balmer ML, Schürch CM, Saito Y, Geuking MB, Li H, Cuenca M, et al. Microbiota-derived compounds drive steady-state granulopoiesis via MyD88/TICAM signaling. J Immunol (2014) 193:5273-83. doi:10.4049/jimmunol.1400762
32. Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood (2014) 124:1174-82. doi:10.1182/blood-2014-02-554725
33. Khosravi A, Yáñez A, Price JG, Chow A, Merad M, Goodridge HS, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe (2014) 15:374-81. doi:10.1016/j.chom.2014.02.006
34. Manzo VE, Bhatt AS. The human microbiome in hematopoiesis and hematologic disorders. Blood (2015) 126:311-8. doi:10.1182/blood-2015-04-574392
35. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med (2014) 20:159-66. doi:10.1038/nm.3444
36. Boiko JR, Borghesi L. Hematopoiesis sculpted by pathogens: toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine (2012) 57:1-8. doi:10.1016/j.cyto.2011.10.005
37. Kovtonyuk LV, Fritsch K, Feng X, Manz MG, Takizawa H. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front Immunol (2016) 7:502. doi:10.3389/fimmu.2016.00502
38. Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med (2011) 208:273-84. doi:10.1084/jem.20101643
39. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 116:3015-25. doi:10.1172/JCI28898
40. Kell DB, Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol (Camb) (2015) 7:1339-77. doi:10.1039/c5ib00158g
41. Barin JG, Tobias LD, Peterson DA. The microbiome and autoimmune disease: report from a Noel R. Rose Colloquium. Clin Immunol (2015) 159:183-8. doi:10.1016/j.clim.2015.05.009
42. Karczewski J, Poniedzialek B, Adamski Z, Rzymski P. The effects of the microbiota on the host immune system. Autoimmunity (2014) 47:494-504. doi:10.3109/08916934.2014.938322
43. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol (2016) 23:5-12. doi:10.1016/j.tracli.2015.11.006
44. Libregts SF, Nolte MA. Parallels between immune driven-hematopoiesis and T cell activation: 3 signals that relay inflammatory stress to the bone marrow. Exp Cell Res (2014) 329:239-47. doi:10.1016/j.yexcr.2014.09.016
45. Bathla L, Grant WJ, Mercer DF, Vargas LM, Gebhart CL, Langnas AN. Parvovirus associated fulminant hepatic failure and aplastic anemia treated successfully with liver and bone marrow transplantation. A report of two cases. Am J Transplant (2014) 14:2645-50. doi:10.1111/ajt.12857
46. Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. Acta Virol (2014) 58:199-213. doi:10.4149/av_2014_03_199
47. Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med (2007) 131:799-804.
48. Wolfromm A, Rodriguez C, Michel M, Habibi A, Audard V, Benayoun E, et al. Spectrum of adult parvovirus B19 infection according to the underlying predisposing condition and proposals for clinical practice. Br J Haematol (2015) 170:192-9. doi:10.1111/bjh.13421
49. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis (2000) 59:672-83. doi:10.1136/ard.59.9.672
50. Thammasri K, Rauhamäki S, Wang L, Filippou A, Kivovich V, Marjomäki V, et al. Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells. PLoS One (2013) 8:e67179. doi:10.1371/journal.pone.0067179
51. Espinoza JL, Takami A, Trung LQ, Kato S, Nakao S. Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells. PLoS One (2012) 7:e51306. doi:10.1371/journal.pone.0051306
52. Long HM, Taylor GS, Rickinson AB. Immune defence against EBV and EBV-associated disease. Curr Opin Immunol (2011) 23:258-64. doi:10.1016/j.coi.2010.12.014
53. Pender MP. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis (2012) 2012:189096. doi:10.1155/2012/189096
54. Yenicesu I, Yetgin S, Ozyürek E, Aslan D. Virus-associated immune thrombocytopenic purpura in childhood. Pediatr Hematol Oncol (2002) 19:433-7. doi:10.1080/08880010290097233
55. Xu LH, Fang JP, Weng WJ, Huang K, Guo HX, Liu Y, et al. Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children. Hematology (2013) 18:56-9. doi:10.1179/1607845412Y.0000000044
56. Gupta V, Pratap R, Kumar A, Saini I, Shukla J. Epidemiological features of aplastic anemia in Indian children. Indian J Pediatr (2013) 81(3):257-9. doi:10.1007/s12098-013-1242-1
57. Shadduck RK, Winkelstein A, Zeigler Z, Lichter J, Goldstein M, Michaels M, et al. Aplastic anemia following infectious mononucleosis: possible immune etiology. Exp Hematol (1979) 7:264-71.
58. Khan IIS, Mushtaq R, Onwuzurike N. EBV infection resulting in aplastic anemia: a case report and literature review. J Blood Disord Transfus (2013) 4:141. doi:10.4172/2155-9864.1000141
59. Santos Souza HF, da Silva Almeida B, Boscardin SB. Early dengue virus interactions: the role of dendritic cells during infection. Virus Res (2016) 223:88-98. doi:10.1016/j.virusres.2016.07.001
60. Clark KB, Noisakran S, Onlamoon N, Hsiao HM, Roback J, Villinger F, et al. Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow. PLoS One (2012) 7:e52902. doi:10.1371/journal.pone.0052902
61. Noisakran S, Onlamoon N, Hsiao HM, Clark KB, Villinger F, Ansari AA, et al. Infection of bone marrow cells by dengue virus in vivo. Exp Hematol (2012) 40:250-9.e254. doi:10.1016/j.exphem.2011.11.011
62. Ramzan M, PrakashYadav S, Sachdeva A. Post-dengue fever severe aplastic anemia: a rare association. Hematol Oncol Stem Cell Ther (2012) 5:122-4. doi:10.5144/1658-3876.2012.122
63. Albuquerque PL, Silva Júnior GB, Diógenes SS, Silva HF. Dengue and aplastic anemia-a rare association. Travel Med Infect Dis (2009) 7:118-20. doi:10.1016/j.tmaid.2009.01.001
64. Nakao S, Lai CJ, Young NS. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood (1989) 74:1235-40.
65. Spain-Santana TA, Marglin S, Ennis FA, Rothman AL. MIP-1 alpha and MIP-1 beta induction by dengue virus. J Med Virol (2001) 65:324-30. doi:10.1002/jmv.2037
66. Calvert JK, Helbig KJ, Dimasi D, Cockshell M, Beard MR, Pitson SM, et al. Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. J Interferon Cytokine Res (2015) 35:654-65. doi:10.1089/jir.2014.0195
67. Clarke JN, Davies LK, Calvert JK, Gliddon BL, Al Shujari WH, Aloia AL, et al. Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. J Gen Virol (2016) 97:95-109. doi:10.1099/jgv.0.000334
68. Mangione JN, Huy NT, Lan NT, Mbanefo EC, Ha TT, Bao LQ, et al. The association of cytokines with severe dengue in children. Trop Med Health (2014) 42:137-44. doi:10.2149/tmh.2014-09
69. Hsu YL, Wang MY, Ho LJ, Lai JH. Dengue virus infection induces interferon-lambda1 to facilitate cell migration. Sci Rep (2016) 6:24530. doi:10.1038/srep24530
70. Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res (2010) 30:555-64. doi:10.1089/jir.2010.0078
71. RauffB, Idrees M, Shah SA, Butt S, Butt AM, Ali L, et al. Hepatitis associated aplastic anemia: a review. Virol J (2011) 8:87. doi:10.1186/1743-422X-8-87
72. Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP, Moreno-Otero R. Systematic review: hepatitis-associated aplastic anaemia-a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther (2009) 30:436-43. doi:10.1111/j.1365-2036.2009.04060.x.
73. Safadi R, Or R, Ilan Y, Naparstek E, Nagler A, Klein A, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant (2001) 27:183-90. doi:10.1038/sj.bmt.1702749
74. Wang H, Tu M, Fu R, Wu Y, Liu H, Xing L, et al. The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China. PLoS One (2014) 9:e98142. doi:10.1371/journal.pone.0098142
75. Khurana A, Dasanu CA. Hepatitis associated aplastic anemia: case report and discussion. Conn Med (2014) 78:493-5.
76. Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood (2004) 103:4588-93. doi:10.1182/blood-2003-11-3959
77. Mayer A, Podlech J, Kurz S, Steffens HP, Maiberger S, Thalmeier K, et al. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol (1997) 71:4589-98.
78. Seifert ME, Brennan DC. Cytomegalovirus and anemia: not just for transplant anymore. J Am Soc Nephrol (2014) 25:1613-5. doi:10.1681/ASN.2014030249
79. Lagadinou ED, Marangos M, Liga M, Panos G, Tzouvara E, Dimitroulia E, et al. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Transpl Infect Dis (2010) 12:437-40. doi:10.1111/j.1399-3062.2010.00515.x
80. Isomura H, Yoshida M, Namba H, Fujiwara N, Ohuchi R, Uno F, et al. Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro. J Gen Virol (2000) 81:663-73. doi:10.1099/0022-1317-81-3-663
81. Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G. Respiratory syncytial virus infection in human bone marrow stromal cells. Am J Respir Cell Mol Biol (2011) 45:277-86. doi:10.1165/rcmb.2010-0121OC
82. Balan A, Lucchini G, Schmidt S, Schneider A, Tramsen L, Kuçi S, et al. Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease-friends or foes? Leukemia (2014) 28:1941-8. doi:10.1038/leu.2014.127
83. Kolb-Mäurer A, Wilhelm M, Weissinger F, Bröcker EB, Goebel W. Interaction of human hematopoietic stem cells with bacterial pathogens. Blood (2002) 100:3703-9. doi:10.1182/blood-2002-03-0898
84. Kim JM, Oh YK, Kim YJ, Youn J, Ahn MJ. Escherichia coli up-regulates proinflammatory cytokine expression in granulocyte/macrophage lineages of CD34 stem cells via p50 homodimeric NF-kappaB. Clin Exp Immunol (2004) 137:341-50. doi:10.1111/j.1365-2249.2004.02542.x
85. Atif FA. Anaplasma marginale and Anaplasma phagocytophilum: rickettsiales pathogens of veterinary and public health significance. Parasitol Res (2015) 114:3941-57. doi:10.1007/s00436-015-4698-2
86. Pozdnyakova O, Dorfman DM. Human granulocytic anaplasmosis. Blood (2012) 120:4911. doi:10.1182/blood-2012-07-445817
87. Ohashi N, Gaowa, Wuritu, Kawamori F, Wu D, Yoshikawa Y, et al. Human granulocytic anaplasmosis, Japan. Emerg Infect Dis (2013) 19:289-92. doi:10.3201/eid1902.120855
88. Johns JL, Macnamara KC, Walker NJ, Winslow GM, Borjesson DL. Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect Immun (2009) 77:4070-80. doi:10.1128/IAI.00570-09
89. Bakken JS, Dumler JS. Human granulocytic anaplasmosis. Infect Dis Clin North Am (2015) 29:341-55. doi:10.1016/j.idc.2015.02.007
90. MacNamara KC, Racine R, Chatterjee M, Borjesson D, Winslow GM. Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. Infect Immun (2009) 77:4061-9. doi:10.1128/IAI.01550-08
91. Singh KJ, Ahluwalia G, Sharma SK, Saxena R, Chaudhary VP, Anant M. Significance of haematological manifestations in patients with tuberculosis. J Assoc Physicians India (2001) 49(788):790-4.
92. Avasthi R, Mohanty D, Chaudhary SC, Mishra K. Disseminated tuberculosis: interesting hematological observations. J Assoc Physicians India (2010) 58:243-4.
93. Chandni R, Rajan G, Udayabhaskaran V. Extra pulmonary tuberculosis presenting as fever with massive splenomegaly and pancytopenia. IDCases (2016) 4:20-2. doi:10.1016/j.idcr.2016.02.005
94. Zeng D, Hoffmann P, Lan F, Huie P, Higgins J, Strober S. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood (2002) 99:1449-57. doi:10.1182/blood. V99.4.1449
95. Urbieta M, Barao I, Jones M, Jurecic R, Panoskaltsis-Mortari A, Blazar BR, et al. Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. Blood (2010) 115:4934-43. doi:10.1182/blood-2009-04-218826
96. Dao AT, Yamazaki H, Takamatsu H, Sugimori C, Katagiri T, Maruyama H, et al. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia. Ann Hematol (2016) 95:771-81. doi:10.1007/s00277-016-2629-7
97. Bendall SC, Simonds EF, Qiu P, Amir el AD, Krutzik PO, Finck R, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (2011) 332:687-96. doi:10.1126/science.1198704
98. Lerner A, Aminov R, Matthias T. Dysbiosis may trigger autoimmune diseases via inappropriate post-translational modification of host proteins. Front Microbiol (2016) 7:84. doi:10.3389/fmicb.2016.00084